What lab tests are indicated for a threatened abortion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Threatened Abortion

For patients presenting with threatened abortion, laboratory tests should include blood type and Rh status, as Rh-negative women require RhIg administration to prevent alloimmunization, especially with heavy bleeding, abdominal pain, or when the event occurs near 12 weeks gestation. 1

Essential Laboratory Tests

  • Blood Type and Rh Status: Critical to identify Rh-negative patients who require RhIg prophylaxis to prevent alloimmunization 2, 1
  • Complete Blood Count (CBC): To assess for anemia from blood loss and evaluate for signs of infection 3
  • Quantitative β-hCG: To confirm pregnancy and establish a baseline for follow-up, though a single low value regardless of gestational age is predictive of abortion 4
  • Blood Group Antibody Screen: To identify patients who may already be alloimmunized 1

Additional Tests Based on Clinical Presentation

  • Progesterone Level: A single low value is highly predictive of abortion regardless of gestational age 4
  • Ultrasound Examination: Though not a laboratory test, it is essential to confirm viability and rule out ectopic pregnancy; absence of fetal life after 9 weeks is invariably followed by abortion 5, 4
  • Quantitative Testing for Fetomaternal Hemorrhage: Consider in cases with significant bleeding to determine if additional doses of RhIg are needed for Rh-negative patients 1

Management of Rh-Negative Patients

  • RhIg Administration: Administer 50 μg of RhIg within 72 hours to Rh-negative women with threatened abortion, especially with heavy bleeding or abdominal pain 2, 1
  • Timing Considerations: RhIg should be given even in early pregnancy since fetal RBCs display RhD antigens from as early as 6 weeks gestation 1
  • Dosing: 50 μg is adequate for first trimester losses; if unavailable, use the standard 300 μg dose 1

Clinical Pearls and Pitfalls

  • Don't Delay Testing: Prompt laboratory evaluation is crucial as 17-30% of threatened abortions progress to spontaneous abortion 3, 6
  • Don't Rely Solely on β-hCG: While important, β-hCG alone cannot accurately predict pregnancy outcome in all cases of threatened abortion 7
  • Don't Overlook Rh Status: Failing to identify and treat Rh-negative patients can lead to alloimmunization and serious complications in future pregnancies 1
  • Consider Gestational Age: The viable pregnancy rate is highest at 6-8 weeks (61.2%) and lowest at 18-20 weeks (20%) 5

Risk Stratification

  • Presence of Subchorionic Hematoma: Associated with higher risk of spontaneous abortion, especially when size exceeds 20 cm² 3
  • Maternal Age: Viable pregnancy rates are highest at maternal age 25-29 years (49%) and lowest at 40-44 years (0%) 5
  • Hormone Combinations: Combined low values of hCG + estradiol or hCG + estriol are invariably followed by abortion from the sixth and eighth weeks onward, respectively 4

References

Guideline

Management Guidelines for Rh Negative Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Outcome of pregnancy complicated by threatened abortion.

Kathmandu University medical journal (KUMJ), 2011

Research

Diagnostic procedures in threatened abortion.

Obstetrics and gynecology, 1984

Research

Sonographic findings in clinically diagnosed threatened abortion.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2001

Research

The outcome of pregnancy after threatened abortion.

Acta obstetricia et gynecologica Scandinavica, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.